Literature DB >> 15672832

Lentiviral transgenesis.

Alexander Pfeifer1.   

Abstract

Transgenic animals are relevant for many fields of modern biomedicine and agriculture. However, the inefficiencies of the presently available techniques--DNA microinjection and retroviral gene transfer--have led to an explosion of costs for transgenics especially in farm animals. The recent success in transferring genes to early embryos of different species (mouse, rat, pig, cattle) by viral vectors derived from lentiviruses, has established lentiviral transgenesis as an exciting alternative to the classical method of DNA microinjection. In addition, lentiviral vectors can be used to transfer genes into embryonic stem cells. Due to its high efficacy and versatility, lentiviral transgenesis should have a big impact on transgenic research.

Entities:  

Mesh:

Year:  2004        PMID: 15672832     DOI: 10.1007/s11248-004-2735-5

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  49 in total

1.  Lentivirus vector gene expression during ES cell-derived hematopoietic development in vitro.

Authors:  I Hamaguchi; N B Woods; I Panagopoulos; E Andersson; H Mikkola; C Fahlman; R Zufferey; L Carlsson; D Trono; S Karlsson
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Strain-dependent differences in the efficiency of transgenic mouse production.

Authors:  Anna B Auerbach; Rada Norinsky; Weilan Ho; Kasia Losos; Qiuxia Guo; Samprit Chatterjee; Alexandra L Joyner
Journal:  Transgenic Res       Date:  2003-02       Impact factor: 2.788

Review 3.  Nuclear transplantation, embryonic stem cells, and the potential for cell therapy.

Authors:  Konrad Hochedlinger; Rudolf Jaenisch
Journal:  N Engl J Med       Date:  2003-07-17       Impact factor: 91.245

4.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

5.  Rhesus monkey placental transgene expression after lentiviral gene transfer into preimplantation embryos.

Authors:  M J Wolfgang; S G Eisele; M A Browne; M L Schotzko; M A Garthwaite; M Durning; A Ramezani; R G Hawley; J A Thomson; T G Golos
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

6.  Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells.

Authors:  Nan Sook Lee; Taikoh Dohjima; Gerhard Bauer; Haitang Li; Ming-Jie Li; Ali Ehsani; Paul Salvaterra; John Rossi
Journal:  Nat Biotechnol       Date:  2002-05       Impact factor: 54.908

7.  Effect of DNA concentration on transgenesis rates in mice and pigs.

Authors:  M B Nottle; K A Haskard; P J Verma; Z T Du; C G Grupen; S M McIlfatrick; R J Ashman; S J Harrison; H Barlow; P L Wigley; I G Lyons; P J Cowan; R J Crawford; P L Tolstoshev; M J Pearse; A J Robins; A J d'Apice
Journal:  Transgenic Res       Date:  2001-12       Impact factor: 2.788

8.  Production of transgenic rabbits, sheep and pigs by microinjection.

Authors:  R E Hammer; V G Pursel; C E Rexroad; R J Wall; D J Bolt; K M Ebert; R D Palmiter; R L Brinster
Journal:  Nature       Date:  1985 Jun 20-26       Impact factor: 49.962

9.  Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs.

Authors:  R L Brinster; H Y Chen; M E Trumbauer; M K Yagle; R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

10.  Transcription start regions in the human genome are favored targets for MLV integration.

Authors:  Xiaolin Wu; Yuan Li; Bruce Crise; Shawn M Burgess
Journal:  Science       Date:  2003-06-13       Impact factor: 47.728

View more
  30 in total

1.  A new method to efficiently produce transgenic embryos and mice from low-titer lentiviral vectors.

Authors:  Kai Miao; Min Guo; Lei An; Xiao Ling Xu; Han Wu; Dong Wang; Zhong Hong Wu; Jian Hui Tian
Journal:  Transgenic Res       Date:  2010-06-29       Impact factor: 2.788

2.  Lentiviral transgenesis in livestock.

Authors:  Simon Lillico; Douglas Vasey; Tim King; Bruce Whitelaw
Journal:  Transgenic Res       Date:  2010-10-07       Impact factor: 2.788

3.  Gene transfer into cardiac myocytes.

Authors:  Sarah E Lang; Margaret V Westfall
Journal:  Methods Mol Biol       Date:  2015

Review 4.  Transgenic pigs as models for translational biomedical research.

Authors:  Bernhard Aigner; Simone Renner; Barbara Kessler; Nikolai Klymiuk; Mayuko Kurome; Annegret Wünsch; Eckhard Wolf
Journal:  J Mol Med (Berl)       Date:  2010-03-26       Impact factor: 4.599

5.  CMV enhancer-promoter is preferentially active in exocrine cells in vivo.

Authors:  D B Vasey; S G Lillico; H M Sang; T J King; C B A Whitelaw
Journal:  Transgenic Res       Date:  2008-12-16       Impact factor: 2.788

Review 6.  New routes for transgenesis of the mouse.

Authors:  José E Belizário; Priscilla Akamini; Philip Wolf; Bryan Strauss; José Xavier-Neto
Journal:  J Appl Genet       Date:  2012-05-09       Impact factor: 3.240

Review 7.  Progress and prospects for genetic modification of nonhuman primate models in biomedical research.

Authors:  Anthony W S Chan
Journal:  ILAR J       Date:  2013

8.  Skin-specifically transgenic expression of biologically active human cytoxic T-lymphocyte associated antigen4-immunoglobulin (hCTLA4Ig) in mice using lentiviral vector.

Authors:  Wen Jiang; Xiao-Yang Zhou; Lu-lu Wang; Qin Liu; Cang'e Liu; Yong Wang; Hong Wei
Journal:  Transgenic Res       Date:  2011-10-08       Impact factor: 2.788

9.  Embryo development, fetal growth and postnatal phenotype of eGFP lambs generated by lentiviral transgenesis.

Authors:  M Crispo; M Vilariño; P C dos Santos-Neto; R Núñez-Olivera; F Cuadro; N Barrera; A P Mulet; T H Nguyen; I Anegón; A Menchaca
Journal:  Transgenic Res       Date:  2014-07-22       Impact factor: 2.788

Review 10.  Transgenic mice and their impact on kidney research.

Authors:  Isabelle Rubera; Edith Hummler; Friedrich Beermann
Journal:  Pflugers Arch       Date:  2008-12-16       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.